Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants.
about
Adjuvants: Classification, Modus Operandi, and LicensingPsychedelics and Immunomodulation: Novel Approaches and Therapeutic OpportunitiesThe Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi InfectionImmunotherapeutic potential of extracellular vesiclesCollaboration of Toll-like and RIG-I-like receptors in human dendritic cells: tRIGgering antiviral innate immune responsesMax Bergmann lecture protein epitope mimetics in the age of structural vaccinologyImpact of heme on specific antibody production in mice: promotive, inhibitive or null outcome is determined by its concentration.Signal transduction by different forms of the γδ T cell-specific pattern recognition receptor WC1.The personal touch: strategies toward personalized vaccines and predicting immune responses to them.MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens.Chasing the recipe for a pro-regenerative immune systemRole of innate immunity in the pathogenesis of otitis mediaFlagellin as carrier and adjuvant in cocaine vaccine development.In vivo and in vitro characterization of the immune stimulating activity of the Neisserial porin PorBThe mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophagesTumor-Associated Glycans and Immune SurveillanceSynthetic RNAs Mimicking Structural Domains in the Foot-and-Mouth Disease Virus Genome Elicit a Broad Innate Immune Response in Porcine Cells Triggered by RIG-I and TLR Activation.Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditisA dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93.The laboratory of genetics and physiology 2: emerging insights into the controversial functions of this RIG-I-like receptor.Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines.Production of IL-1β and Inflammasome with Up-Regulated Expressions of NOD-Like Receptor Related Genes in Toxoplasma gondii-Infected THP-1 Macrophages.Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques.The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells.Toll-Like Receptor Ligand-Based Vaccine Adjuvants Require Intact MyD88 Signaling in Antigen-Presenting Cells for Germinal Center Formation and Antibody Production.Carbohydrate-based cancer vaccines: target cancer with sugar bullets.Systematic identification of small molecule adjuvants.Influenza vaccines: T-cell responses deserve more attention.Fibroblast autophagy in fibrotic disorders.Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic.Cancer vaccine adjuvants--recent clinical progress and future perspectives.Recent advances in vaccine delivery.RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration.Immunological effects of a novel RNA-based adjuvant in liver cancer patients.Retrovirus-based Virus-Like Particle Immunogenicity and its Modulation by Toll-Like Receptor Activation.Use of adjuvants for immunotherapy.Apoptosis, Toll-like, RIG-I-like and NOD-like Receptors Are Pathways Jointly Induced by Diverse Respiratory Bacterial and Viral Pathogens.Mannan Derivatives Instruct Dendritic Cells to Induce Th1/Th2 Cells Polarization via Differential Mitogen-Activated Protein Kinase Activation.Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae.Antimicrobial peptides for gram-negative sepsis: a case for the polymyxins.
P2860
Q26747586-93891E1F-ADFC-4EE0-B1F7-BAB9ED3FA765Q26799997-81561186-516C-43AB-9F02-B6694C2DB470Q26829884-0FC315DD-84D6-4CC9-883D-AC405116D999Q27023323-84C1E136-BEC4-45FD-918F-3AC332C281F6Q27025891-C30D14FD-B47E-4A8D-A40E-DEC8FB0FA416Q30155145-944E3B9F-F16A-4787-9F19-9F534CC8F906Q33700146-815F1708-F79C-4A91-B79A-E4BF28513A6AQ33795825-3EABA7AE-2C24-4FCE-9542-89A880145205Q33813977-38F7C9F1-16DE-4907-8CA0-07920583CF0DQ34506918-C6602BF1-8E27-4117-8121-0B657ADDCEE0Q34537287-25467A02-DE6C-4DDD-AD8F-5A419FB320B8Q35027403-F8089CFF-CA72-4BE3-A666-EB0E04A5A990Q35057556-046CEF07-ECBF-4641-A5E0-C611796DD966Q35070034-FE1DA9EA-A2D4-419F-A06A-6E9EA643394EQ35154923-49231D1C-66FD-4700-A2FA-BB4350D89EA9Q35890610-C33108E2-FC56-4FD3-B8C5-134BEF72C571Q35895331-423947F7-01DA-4C9B-992D-5F2A7A45EED7Q36977614-2EED2C05-F59C-4545-8E98-6475F1E5DF07Q37431320-D5921DA2-6FAB-4249-965C-A7E6AB8300A1Q37556622-90E9FC31-91B9-4F3C-B799-A50BD617D0DEQ37584248-4CADBC89-37B1-4042-82AD-0E6743980ED5Q37606562-833FE580-2BC3-4284-8AB3-4473BE2DEFFBQ37643792-015D0E31-126A-4CF7-91F1-872AD0116F19Q37653873-117A5CE8-9B9E-4A55-829C-E3B95BC3FBB0Q37677962-94257113-48FF-4A54-BAD5-AAF2B0B2CCB4Q38016342-2DE1C526-C486-42AE-AD76-A6D1AB7503DBQ38020881-B0B1C954-AE32-4A1E-AA9F-269BE2AFEF1CQ38045918-68EAFCE9-38E3-40A6-B6D7-1ECB1EAE2509Q38047232-E7854FA6-D25D-4712-900A-8E47EA97EB82Q38084050-57776185-9EB2-4E43-9337-6E5D24BB3FC2Q38260496-476A047A-C52E-4B4B-93FD-2134D74B7F8AQ38669255-2BD6A610-E599-4E31-B2F8-21215A19507DQ39123617-52346BCD-C38C-497B-AFE6-0D38FFE37059Q39198568-4B1ADBFA-AA49-46D4-9CDE-0BFC090279DBQ40088773-1D89FB44-E597-44E5-90FE-DE2A4BCF6EF7Q40163884-43F00537-6AEF-447F-B1FE-CF1232B5BF21Q40290315-9DA714A2-37BD-4550-8C12-FA25ADB3578EQ41019947-DB8D3575-00E0-469F-8D52-69B85F8CA796Q41613542-0E1BD324-DB1A-459F-A3DF-70FBB7C10843Q42276631-BA72BE84-9055-4B6E-B1ED-8A0734598A8B
P2860
Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pattern recognition receptors: ...... gets of new vaccine adjuvants.
@en
Pattern recognition receptors: ...... gets of new vaccine adjuvants.
@nl
type
label
Pattern recognition receptors: ...... gets of new vaccine adjuvants.
@en
Pattern recognition receptors: ...... gets of new vaccine adjuvants.
@nl
prefLabel
Pattern recognition receptors: ...... gets of new vaccine adjuvants.
@en
Pattern recognition receptors: ...... gets of new vaccine adjuvants.
@nl
P2860
P356
P1476
Pattern recognition receptors: ...... gets of new vaccine adjuvants.
@en
P2093
Colleen Olive
P2860
P304
P356
10.1586/ERV.11.189
P577
2012-02-01T00:00:00Z